AGP Picks
View all

Health Update Bahamas
Provided by AGP

Health Update Bahamas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Update Bahamas.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on July 21, 2026

Applied Biologics Initiates Multi-Center Real-World Outcomes Study of XWRAP® Across Chronic Wound Types
Jul. 21, 2026

Applied Biologics Initiates Multi-Center Real-World Outcomes Study of XWRAP® Across Chronic Wound Types

Indeterminate GlobeNewswire
Akari Therapeutics Enters Strategic Research Collaboration with Whitehawk Therapeutics
Jul. 21, 2026

Akari Therapeutics Enters Strategic Research Collaboration with Whitehawk Therapeutics

Indeterminate GlobeNewswire
Kraig Biocraft Laboratories CEO Kim Thompson Featured in Just Style, a Leading Global Apparel Industry Trade Publication
Jul. 21, 2026

Kraig Biocraft Laboratories CEO Kim Thompson Featured in Just Style, a Leading Global Apparel Industry Trade Publication

Indeterminate GlobeNewswire
Axiom Biosciences Announces Intention to Become the First U.S. Biotech to List on the Hong Kong Stock Exchange
Jul. 21, 2026

Axiom Biosciences Announces Intention to Become the First U.S. Biotech to List on the Hong Kong Stock Exchange

Indeterminate GlobeNewswire
R1 Therapeutics announces commencement of global Phase 2b trial of AP306 for hyperphosphatemia in patients on dialysis
Jul. 21, 2026

R1 Therapeutics announces commencement of global Phase 2b trial of AP306 for hyperphosphatemia in patients on dialysis

Indeterminate GlobeNewswire
PharmAla Biotech Executes Definitive License Agreement Granting Jupiter Neurosciences Exclusive U.S. Rights to ALA-002
Jul. 21, 2026

PharmAla Biotech Executes Definitive License Agreement Granting Jupiter Neurosciences Exclusive U.S. Rights to ALA-002

Indeterminate GlobeNewswire
Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice
Jul. 21, 2026

Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice

Indeterminate GlobeNewswire
Tempest Announces Development Collaboration with Senlang Biotechnology for TPST-4003, a CD7-Targeted Next-Generation In Vivo CAR-T
Jul. 21, 2026

Tempest Announces Development Collaboration with Senlang Biotechnology for TPST-4003, a CD7-Targeted Next-Generation In Vivo CAR-T

Indeterminate GlobeNewswire
Agios Provides Update on Phase 2 Trial of Tebapivat in Sickle Cell Disease
Jul. 21, 2026

Agios Provides Update on Phase 2 Trial of Tebapivat in Sickle Cell Disease

Indeterminate GlobeNewswire
Pasithea Therapeutics Announces Presentation of PAS-004 Data to European Society for Medical Oncology (ESMO) Congress 2026
Jul. 21, 2026

Pasithea Therapeutics Announces Presentation of PAS-004 Data to European Society for Medical Oncology (ESMO) Congress 2026

Indeterminate GlobeNewswire
OKYO Pharma Announces Purchase of Shares by Chairman
Jul. 21, 2026

OKYO Pharma Announces Purchase of Shares by Chairman

Indeterminate GlobeNewswire
BioNTech veröffentlicht am 4. August 2026 Ergebnisse für das zweite Quartal 2026 und informiert über operativen Fortschritt
Jul. 21, 2026

BioNTech veröffentlicht am 4. August 2026 Ergebnisse für das zweite Quartal 2026 und informiert über operativen Fortschritt

Indeterminate GlobeNewswire
BioNTech to Report Second Quarter 2026 Financial Results and Corporate Update on August 4, 2026
Jul. 21, 2026

BioNTech to Report Second Quarter 2026 Financial Results and Corporate Update on August 4, 2026

Indeterminate GlobeNewswire
Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study
Jul. 21, 2026

Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study

Indeterminate GlobeNewswire
Allogenetics Appoints Dr. Jeroen Rovers as Chief Medical Officer
Jul. 21, 2026

Allogenetics Appoints Dr. Jeroen Rovers as Chief Medical Officer

Indeterminate GlobeNewswire
Enterome Phase 2 data show EO2463-induced CD8 T-cell expansion correlates with progression-free survival in patients with indolent non-Hodgkin lymphoma in the watch-and-wait setting
Jul. 21, 2026

Enterome Phase 2 data show EO2463-induced CD8 T-cell expansion correlates with progression-free survival in patients with indolent non-Hodgkin lymphoma in the watch-and-wait setting

Indeterminate GlobeNewswire
OMEICOS’ OMT-28 Headed for Phase 3 in Primary Mitochondrial Diseases (PMD) Following Positive End-of-Phase 2 Meeting with the FDA
Jul. 21, 2026

OMEICOS’ OMT-28 Headed for Phase 3 in Primary Mitochondrial Diseases (PMD) Following Positive End-of-Phase 2 Meeting with the FDA

Indeterminate GlobeNewswire
Carbios reaches milestone of 100 batches at its Industrial demonstration plant and expands its licensing offering to the textile market
Jul. 21, 2026

Carbios reaches milestone of 100 batches at its Industrial demonstration plant and expands its licensing offering to the textile market

Indeterminate GlobeNewswire
Carbios franchit le cap des 100 batchs produits au sein de son démonstrateur industriel et étend son offre de licences au marché textile
Jul. 21, 2026

Carbios franchit le cap des 100 batchs produits au sein de son démonstrateur industriel et étend son offre de licences au marché textile

Indeterminate GlobeNewswire

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Update Bahamas

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.